GB202015190D0 - Immunotherapy - Google Patents
ImmunotherapyInfo
- Publication number
- GB202015190D0 GB202015190D0 GBGB2015190.8A GB202015190A GB202015190D0 GB 202015190 D0 GB202015190 D0 GB 202015190D0 GB 202015190 A GB202015190 A GB 202015190A GB 202015190 D0 GB202015190 D0 GB 202015190D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- immunotherapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2015190.8A GB202015190D0 (en) | 2020-09-25 | 2020-09-25 | Immunotherapy |
EP21786350.5A EP4217374A1 (en) | 2020-09-25 | 2021-09-24 | Immunotherapy |
PCT/EP2021/076412 WO2022064011A1 (en) | 2020-09-25 | 2021-09-24 | Immunotherapy |
US18/028,658 US20230357388A1 (en) | 2020-09-25 | 2021-09-24 | Immunotherapy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2015190.8A GB202015190D0 (en) | 2020-09-25 | 2020-09-25 | Immunotherapy |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202015190D0 true GB202015190D0 (en) | 2020-11-11 |
Family
ID=73197216
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2015190.8A Ceased GB202015190D0 (en) | 2020-09-25 | 2020-09-25 | Immunotherapy |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202015190D0 (en) |
-
2020
- 2020-09-25 GB GBGB2015190.8A patent/GB202015190D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3823639A4 (en) | Msc- and exosome-based immunotherapy | |
EP3909590A4 (en) | Cellular immunotherapy combination | |
GB202100855D0 (en) | No details | |
GB201903229D0 (en) | Immunotherapy | |
IL289006A (en) | Combination cancer immunotherapy | |
GB202013962D0 (en) | Immunotherapy composition | |
IL291343A (en) | Immunotherapy compounds and methods | |
GB202113795D0 (en) | No details | |
GB202113696D0 (en) | No details | |
GB202115468D0 (en) | No details | |
GB202111207D0 (en) | No details | |
GB202018395D0 (en) | Immunotherapy | |
GB202015190D0 (en) | Immunotherapy | |
GB202010095D0 (en) | Immunotherapy | |
EP4048780A4 (en) | Adoptive immunotherapy | |
GB201821205D0 (en) | Immunotherapy | |
EP4031872C0 (en) | Immunotherapy markers | |
GB202009434D0 (en) | Novel viralyser | |
GB202101009D0 (en) | Novel methods | |
IL284816A (en) | Methods for improved immunotherapy | |
GB202002315D0 (en) | Novel methods | |
GB202001443D0 (en) | Novel methods | |
GB202206179D0 (en) | No details | |
GB202206211D0 (en) | No details | |
GB202111723D0 (en) | No details |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |